e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
COPD: symptoms and staging
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Novel patterns of serum biomarkers profiling using minimal important clinical outcomes (MICO) in the longidutinal study BODE cohort of COPD patients
C. Casanova, V. Pinto-Plata, J. P. de Torres, H. Mullerova, H. Corado, N. Varo, R. Baz, E. Cordoba, S. Zeineldine, B. Celli (Tenerife, Pamplona, Spain; Boston, United States Of America; London, United Kingdom)
Source:
Annual Congress 2010 - COPD: symptoms and staging
Session:
COPD: symptoms and staging
Session type:
Oral Presentation
Number:
5550
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Casanova, V. Pinto-Plata, J. P. de Torres, H. Mullerova, H. Corado, N. Varo, R. Baz, E. Cordoba, S. Zeineldine, B. Celli (Tenerife, Pamplona, Spain; Boston, United States Of America; London, United Kingdom). Novel patterns of serum biomarkers profiling using minimal important clinical outcomes (MICO) in the longidutinal study BODE cohort of COPD patients. Eur Respir J 2010; 36: Suppl. 54, 5550
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
SGRQ-C distribution in the evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) cohort: Characteristics of COPD subjects with extreme score quintiles
Source: Annual Congress 2010 - COPD: symptoms and staging
Year: 2010
Blood biomarkers in COPD: results from the ECLIPSE (evaluation of COPD longitudinally to identify predictive surrogate endpoints) cohort
Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD
Year: 2009
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Development of a new prognosis index (BODS) in patients with COPD:a prospective cohort study
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018
Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up
Source: International Congress 2014 – Markers
Year: 2014
Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Novel method of expressing serum biomarkers profiling in COPD patients: The heatmap-clinical pattern profile
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Distribution of T2 markers in real-life patients with asthma, COPD and asthma+COPD from the BREATHE study
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
A longitudinal study of the relationship between serial changes in BODE index, mortality and readmissions in patients with COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
FEV
6
: a useful outcome measure of lung function in COPD as assessed in a large clinical study with roflumilast
Source: Eur Respir J 2004; 24: Suppl. 48, 342s
Year: 2004
Blood biomarkers predicting disease progression in patients with IPF: data from the INMARK trial
Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia
Year: 2019
Gender differences in health status in patients with COPD: baseline characteristics of a multi-centre intervention and characterisation study on Seretide (COSMIC)
Source: Eur Respir J 2002; 20: Suppl. 38, 262s
Year: 2002
Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
COPD characteristics and progression of patients with high vs low health status: an analysis of the observational DACCORD study
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
Microarray profiling of COPD patients versus non-COPD smokers reveals possible disease biomarkers
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Mortality and prognostic factors in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
An international prospective cohort study to develop a practical COPD disease risk index that predicts the clinical course of COPD
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept